会社概要
- 正式社名: Pfizer CentreOne
- 国際名称: Pfizer CentreOne, contract manufacturing arm of Pfizer Inc.
- ブランド名 / 商号: Pfizer CentreOne
- 登録国: United States
- 住所: Corporate Headquarters: 235 E. 42nd Street, New York, NY 10017
- 従業員数: 50 - 99
説明:
Pfizer CentreOne helps maximize product potential and reach patients faster, providing premium commercial manufacturing for oral solids, sterile injectables and biologic drug products as a reliable extension of customers' networks. Customers gain direct access to Pfizer's network of global sites, benefiting from cutting-edge process optimization, scalable commercial manufacturing solutions and secure supply chains; powered by Pfizer, the company has spent decades earning an uncompromising reputation for quality dedicated to the rapid delivery of client projects.
事業活動
原薬(API)
原薬メーカー
受託・アウトソーシングサービス
医薬品開発製造受託機関(CDMO)サービスプロバイダー受託製造業者(CMO)
薬事・市場調査サービス
サービスプロバイダー
完成医薬品(製剤)
受託製造業者(CMO)
製造設備・プラントユーティリティ
受託製造業者(CMO)
包装資材
受託製造業者(CMO)
バイオ医薬品
受託製造業者(CMO)
販売市場
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
主要製品/サービス
- 原薬(API): Active Pharmaceutical Ingredients
- 受託・アウトソーシングサービス: Antibody Drug Conjugate (ADC) Contract Manufacturing, Microbial Fermentation Contract Manufacturing, Oral Solid Dosage (OSD) Contract Manufacturing, Sterile Injectables Contract Manufacturing, Aseptic Filling
- 完成医薬品(製剤): Sterile Injectables and non injectables
- バイオ医薬品: Gene and Cell Therapy
当社の製品・サービス
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
認証
CEP証明書
DMF
FDA
GMP
ISO
証明
CPHI Americas 2026
06/2026 – 06/2026
CPHI Americas 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す